A woman aged 55 years has herpes zoster that affects the trigeminal nerve on the right side of her face. The post-herpetic pain is continuous and unbearable. Multiple drugs, including gabapentin ...
Crisugabalin — an oral calcium channel alpha 2 delta-1 subunit ligand — was safe and well-tolerated at doses of 40 mg/d and 80 mg/d and significantly reduced pain scores in patients with postherpetic ...
The product is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Bondlido ® (lidocaine topical system 10%) for the relief of pain associated with ...
Lexicon Pharmaceuticals has missed the mark in a phase 2 aiming to treat a common complication of shingles known as postherpetic neuralgia. However, the Texas biotech is standing by its therapy, ...
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ZTlido ® (lidocaine topical system; Scilex Pharmaceuticals) to include additional ...
BOSTON -- An investigational medication that, if approved, would be a first-in-class treatment for post-herpetic neuralgia (PHN) still has a future despite missing the primary efficacy endpoint in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results